149 related articles for article (PubMed ID: 5983695)
21. [Odeston in treatment of chronic diseases of hepatobiliary system].
Nasonova SV; Lebedeva OI
Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
[No Abstract] [Full Text] [Related]
22. [Personal experiences in the treatment of bile duct diseases using Genebil].
De Marcos Perez VM
Rev Esp Enferm Apar Dig; 1969 Nov; 29(4):569-84. PubMed ID: 5363141
[No Abstract] [Full Text] [Related]
23. [Choleretics].
Tagliareni F
Minerva Nipiol; 1967; 17(4):136-41. PubMed ID: 5620855
[No Abstract] [Full Text] [Related]
24. [Clinical and radiological study of a new synthetic cholereretic agent].
Strata A; Arsenio L; Marcato M; Maccarini PA
Clin Ter; 1971 Oct; 59(2):117-35. PubMed ID: 5141388
[No Abstract] [Full Text] [Related]
25. [Effect of xylite on hepatic and pancreatic function in biliary pathology].
Rafes IuI; Sheleketina II; Voroteliak VS; Kulikova ZS; Mel'nichenko LIa
Vrach Delo; 1972 Feb; 2():10-4. PubMed ID: 5084716
[No Abstract] [Full Text] [Related]
26. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
Nogaller AM; Barkhanova AG; Zakharova GIu
Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
[No Abstract] [Full Text] [Related]
27. From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament.
Makino I; Tanaka H
J Gastroenterol Hepatol; 1998 Jun; 13(6):659-64. PubMed ID: 9715413
[No Abstract] [Full Text] [Related]
28. [Clinical trial of an hepatobiliary analeptic agent].
Chapuy H; Jeune M; Sambin P; Girard M
J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331
[No Abstract] [Full Text] [Related]
29. [Assessment of the cholagogic effect of sunflower seed oil and magnesium sulfate on the basis of the urocholecystokinin level].
Popova EA; Gol'tiakova TV
Sov Med; 1969 Apr; 32(4):57-62. PubMed ID: 5378880
[No Abstract] [Full Text] [Related]
30. [Cholagogic agents].
Pasichnyk IKh
Farm Zh; 1978; (2):39-43. PubMed ID: 658339
[No Abstract] [Full Text] [Related]
31. [Effect of Cholipin on bile formation and secretion, its therapeutic spectrum].
Andrejević M; Stanković S
Med Glas; 1968 Nov; 22(11):389-91. PubMed ID: 5200353
[No Abstract] [Full Text] [Related]
32. [Current status of hepatic and biliary drug therapy. Part I].
Donatelli L; Marmo E
Clin Ter; 1976 Mar; 76(5):395-409. PubMed ID: 791566
[No Abstract] [Full Text] [Related]
33. [Enzyme substitution therapy in digestive system diseases with special consideration of patients treated with tuberculostatic agents].
Piacenza F
Med Welt; 1967 May; 21():1321-5. PubMed ID: 5612545
[No Abstract] [Full Text] [Related]
34. [The effects of drugs on extrahepatic bile ducts].
Ritter U
Med Klin; 1979 Jul; 74(27):1047-52. PubMed ID: 470790
[No Abstract] [Full Text] [Related]
35. [Clinical experiences with the amphocholereticum Oddibil].
Zawodsky L
Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
[No Abstract] [Full Text] [Related]
36. [Studies on the potency of action of several choleretics].
Mörsdorf K; Wolf G
Dtsch Med J; 1966 May; 17(10):303-6. PubMed ID: 5985421
[No Abstract] [Full Text] [Related]
37. [Functional biliary pathology (clinico-therapeutic considerations)].
Cabezas Cerrato J
Med Clin (Barc); 1965 Apr; 44(4):222-43. PubMed ID: 5834017
[No Abstract] [Full Text] [Related]
38. [A rationale for the use of Carlsbad salt-enriched water in treating patients with biliary tract diseases at a sanatorium].
Ignatova NZ; Garkavi EG
Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (6):50-1. PubMed ID: 2534242
[No Abstract] [Full Text] [Related]
39. [Present status of cholagogue and choleretic medication in biliary disorders].
DEBRAY C; HARDOUIN JP
Rev Prat; 1962 Feb; 12():596-9. PubMed ID: 13884680
[No Abstract] [Full Text] [Related]
40. [Treatment of biliary tract diseases].
Dumitraşcu D
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(3):171-4. PubMed ID: 764
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
